Abstract
The in vitro susceptibilities of 112 clinical isolates of Haemophilus ducreyi to six antimicrobial agents were determined. These isolates were obtained in Kigali, Rwanda, during three studies on genital ulcer disease performed in 1986 (18 isolates), 1988 (23 isolates), and 1991 (71 isolates). All H. ducreyi isolates were susceptible to azithromycin, ceftriaxone, ciprofloxacin, and erythromycin; all isolates obtained in 1986 were also susceptible to trimethoprim and to the combination trimethoprim-sulfamethoxazole. In contrast, 39 and 9% of the isolates obtained in 1988 and 59 and 48% of the isolates obtained in 1991 were resistant to trimethoprim (MIC, > or = 4.0 mg/liter) and trimethoprim-sulfamethoxazole (MIC, < or = 4.0/76 mg/liter), respectively. These data indicate that trimethoprim-sulfamethoxazole can no longer be recommended for use in the treatment of chancroid in Rwanda, and possibly elsewhere in Africa.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abeck D., Johnson A. P., Dangor Y., Ballard R. C. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa. J Antimicrob Chemother. 1988 Oct;22(4):437–444. doi: 10.1093/jac/22.4.437. [DOI] [PubMed] [Google Scholar]
- Aldridge K. E., Cammarata C., Martin D. H. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi. Antimicrob Agents Chemother. 1993 Sep;37(9):1986–1988. doi: 10.1128/aac.37.9.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bogaerts J., Ricart C. A., Van Dyck E., Piot P. The etiology of genital ulceration in Rwanda. Sex Transm Dis. 1989 Jul-Sep;16(3):123–126. doi: 10.1097/00007435-198907000-00001. [DOI] [PubMed] [Google Scholar]
- Dangor Y., Ballard R. C., Miller S. D., Koornhof H. J. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1990 Jul;34(7):1303–1307. doi: 10.1128/aac.34.7.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foster T. J. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev. 1983 Sep;47(3):361–409. doi: 10.1128/mr.47.3.361-409.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knapp J. S., Back A. F., Babst A. F., Taylor D., Rice R. J. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob Agents Chemother. 1993 Jul;37(7):1552–1555. doi: 10.1128/aac.37.7.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motley M., Sarafian S. K., Knapp J. S., Zaidi A. A., Schmid G. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States. Antimicrob Agents Chemother. 1992 Aug;36(8):1639–1643. doi: 10.1128/aac.36.8.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plourde P. J., D'Costa L. J., Agoki E., Ombette J., Ndinya-Achola J. O., Slaney L. A., Ronald A. R., Plummer F. A. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis. 1992 May;165(5):949–952. doi: 10.1093/infdis/165.5.949. [DOI] [PubMed] [Google Scholar]
- Plummer F. A., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Ellison R. H., Ronald A. R. Single-dose therapy of chancroid with trimethoprim-sulfametrole. N Engl J Med. 1983 Jul 14;309(2):67–71. doi: 10.1056/NEJM198307143090202. [DOI] [PubMed] [Google Scholar]
- Schmid G. P. Treatment of chancroid, 1989. Rev Infect Dis. 1990 Jul-Aug;12 (Suppl 6):S580–S589. doi: 10.1093/clinids/12.supplement_6.s580. [DOI] [PubMed] [Google Scholar]
- Taylor D. N., Pitarangsi C., Echeverria P., Panikabutra K., Suvongse C. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis. 1985 Nov;152(5):1002–1006. doi: 10.1093/infdis/152.5.1002. [DOI] [PubMed] [Google Scholar]
- Tyndall M., Malisa M., Plummer F. A., Ombetti J., Ndinya-Achola J. O., Ronald A. R. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis. 1993 Feb;167(2):469–471. doi: 10.1093/infdis/167.2.469. [DOI] [PubMed] [Google Scholar]